US Patent Issued to SALK INSTITUTE FOR BIOLOGICAL STUDIES, SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE on April 7 for "Macrocyclic ULK1/2 inhibitors" (California Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,277, issued on April 7, was assigned to SALK INSTITUTE FOR BIOLOGICAL STUDIES (La Jolla, Calif.) and SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE (La Jolla, Calif.).

"Macrocyclic ULK1/2 inhibitors" was invented by Nicholas D. P. Cosford (La Jolla, Calif.), Nicole A. Bakas (La Jolla, Calif.), Reuben J. Shaw (La Jolla, Calif.), Allison S. Limpert (La Jolla, Calif.) and Sonja N. Brun (La Jolla, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure is directed to compounds, compositions, formulations and methods of use thereof in the treatment and prevention of ULK mediated diseases, including cancer."

The patent was filed ...